Peptide Nanoparticles for Oligonucleotide Delivery

被引:13
作者
Lehto, Taavi [1 ]
Ezzat, Kariem [2 ]
Langel, Uelo [1 ,2 ]
机构
[1] Univ Tartu, Inst Technol, Mol Biotechnol Lab, EE-50090 Tartu, Estonia
[2] Stockholm Univ, Arrhenius Labs Nat Sci, Dept Neurochem, S-10691 Stockholm, Sweden
来源
NANOPARTICLES IN TRANSLATIONAL SCIENCE AND MEDICINE | 2011年 / 104卷
关键词
CELL-PENETRATING PEPTIDES; ARGININE-RICH PEPTIDES; EFFICIENT SIRNA DELIVERY; SMALL INTERFERING RNA; MORPHOLINO OLIGOMERS; GENE-TRANSFER; IN-VITRO; VIRAL VECTORS; MECHANISM; THERAPY;
D O I
10.1016/B978-0-12-416020-0.00010-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the past two decades, different methods have emerged for intervention with gene expression, which can be generally referred to as gene therapy. Oligonucleotides (ONs) and their analogs form the basis of the molecules that can be used to modulate gene expression. Unfortunately, due to their physicochemical properties, these molecules require assistance in their intracellular delivery. Cell-penetrating peptides (CPPs) are one class of nonviral delivery vectors that, because of their remarkable translocation properties, have been intensely utilized for the delivery, of ON-based molecules, both in vitro and in vivo. This chapter concentrates on the applications of CPPs that directly form nanopartides with different ONs and facilitate their intracellular delivery.
引用
收藏
页码:397 / 426
页数:30
相关论文
共 87 条
[1]   Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies [J].
Abes, Rachida ;
Moulton, Hong M. ;
Clair, Philippe ;
Yang, Sung-Tae ;
Abes, Said ;
Melikov, Kamran ;
Prevot, Paul ;
Youngblood, Derek S. ;
Iversen, Patrick L. ;
Chernomordik, Leonid V. ;
Lebleu, Bernard .
NUCLEIC ACIDS RESEARCH, 2008, 36 (20) :6343-6354
[2]   Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents [J].
Abes, Said ;
Moulton, Hong M. ;
Clair, Philippe ;
Prevot, Paul ;
Youngblood, Derek S. ;
Wu, Rebecca P. ;
Iversen, Patrick L. ;
Lebleu, Bernard .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (03) :304-313
[3]  
Andaloussi SEL, 2011, METHODS MOL BIOL, V683, P361, DOI 10.1007/978-1-60761-919-2_26
[4]   Therapeutic Potential of Splice-Switching Oligonucleotides [J].
Bauman, John ;
Jearawiriyapaisarn, Natee ;
Kole, Ryszard .
OLIGONUCLEOTIDES, 2009, 19 (01) :1-13
[5]   Chemical Modification of Oligonucleotides for Therapeutic, Bioanalytical and other Applications [J].
Bell, Neil M. ;
Micklefield, Jason .
CHEMBIOCHEM, 2009, 10 (17) :2691-2703
[6]  
Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO
[7]  
2-T
[8]   Happy birthday cell penetrating peptides: Already 20 years [J].
Brasseur, Robert ;
Divita, Gilles .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2010, 1798 (12) :2177-2181
[9]   Basic research tries to decrease the risks of translational medicine [J].
Cavazzana-Calvo, M. .
GENE THERAPY, 2009, 16 (03) :309-310
[10]   Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growth [J].
Crombez, Laurence ;
Morris, May Catherine ;
Dufort, Sandrine ;
Aldrian-Herrada, Gudrun ;
Nguyen, Quan ;
Mc Master, Gary ;
Coll, Jean-Luc ;
Heitz, Frederic ;
Divita, Gilles .
NUCLEIC ACIDS RESEARCH, 2009, 37 (14) :4559-4569